The atherosclerotic properties of low-density lipoproteins (LDL) are thought to be strongly enhanced by oxidation. The lipid-lowering drug probucol reduces the susceptibility of LDL to oxidation. Synchrotron X-ray and high-flux neutron solution scattering curves were used to characterise the structural properties of human LDL, before and after modification by oxidation with CuZt and the addition of probucol, in order to evaluate these techniques. Analyses based on Guinier plots, simple two-shell spherical modelling, and the use of cubic splines and indirect transformation show that a 20-h incubation with Cu2+ ions (but not 6 h) causes some of the LDL to associate to form larger aggregated particles. Gel electrophoresis on Cu2+-oxidised LDL shows a concomitant degradation of the apolipoprotein B-100 as well as the formation of high molecular mass forms. These experiments indicate that the apoprotein B-100 structure has been significantly disrupted by oxidation. The addition of probucol to LDL causes an increase in the polydispersity of LDL, as evidenced by small changes in the Guinier curves and some weakening of the minima in the X-ray scattering curves. N o changes in the quasispherical shape of LDL are observed and gel electrophoresis indicates no changes. It is possible that probucol may exert its effect by increasing the range of sizes of LDL and that the lipid-lowering effect of probucol in vivo might be caused by the preferential catabolism of the higher molecular mass forms of LDL thus created.Cardiovascular disease is implicated in half of all deaths in industrialised countries. Epidemiological studies show a strong positive correlation between elevated plasma concentrations of low-density lipoproteins (LDL) cholesterol and the risk of premature coronary heart disease [l, 21. The role of LDL is to deliver cholesterol to body tissues which require it for membrane synthesis and steroid hormone production [3]. LDL is distinguishable from all other lipoprotein classes in plasma by its high relative proportion of cholesteryl ester and the presence of a single apolipoprotein (apo) B-100. LDL has a simple quasi-spherical particle symmetry of outer diameter 21 -25 nm, as determined by electron microscopy and solution scattering [4 -81. It is composed of one molecule of apo B-100 with a 4% (by mass) oligosaccharide content (Table 1) and its binding to lipid can be likened to its insertion into a lipid vesicle [8 -121. Compositional studies show that LDL is 77% (by mass) lipid. There are about 2900 lipid molecules (Table l), primarily cholesteryl linoleate and triacylglycerol in the core, surrounded by a monolayer of polar phospholipids and cholesterol. Secondary structure predictions, circular dichroism and Fourier-transform infrared (FT-IR) spectroscopy show that apo B-100 is approximately 40% cc-helix, 25% fl-sheet and 35% random coil in its main chain conformation [9, 11, 13 - B-100 are found at the N-terminus, this part is presumed to constitute a globular structure.The presence of lipid-laden foam cells is a...